tiprankstipranks
Corbus Pharmaceuticals (CRBP)
NASDAQ:CRBP
US Market

Corbus Pharmaceuticals (CRBP) Income Statement

Compare
2,338 Followers

Corbus Pharmaceuticals Income Statement

Last quarter (Q3 2024), Corbus Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Corbus Pharmaceuticals's net income was $-13.78M. See Corbus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 881.71K$ 3.94M$ 36.14M
Gross Profit
$ -31.17M$ -1.49M$ -757.53K$ 3.84M$ 36.05M
Operating Expenses
$ 13.91M$ 34.84M$ 56.87M$ 126.75M$ 113.25M
Depreciation and Amortization
$ 641.00K$ 1.49M$ 1.64M$ 1.69M$ 1.23M
EBITDA
$ -44.44M$ -38.73M$ -54.97M$ -121.69M$ -76.37M
Operating Income
$ -45.08M$ -39.84M$ -55.99M$ -122.81M$ -77.10M
Other Income/Expenses
$ 473.99K$ -2.51M$ 10.35M$ 11.54M$ 5.65M
Pretax Income
$ -44.60M$ -42.35M$ -45.64M$ -111.27M$ -71.45M
Net Income
$ -44.60M$ -55.83M$ -45.55M$ -111.30M$ -69.15M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -10.31$ -13.39$ -11.11$ -42.74$ -32.47
Diluted EPS
$ -10.31$ -13.39$ -11.11$ -42.74$ -32.47
Weighted Average Shares Outstanding
4.33M 4.17M 4.10M 2.60M 2.13M
Weighted Average Shares Outstanding (Diluted)
4.33M 4.17M 4.10M 2.60M 2.13M
Currency in USD

Corbus Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis